Increasingly, injectable manufacturers recognise that to achieve maximum profitability, they need to focus on the value they ...

Our research on cell-based therapies also includes cutting-edge immunotherapies ... The device may help pave the way toward making gene therapy accessible and affordable beyond a handful of ...

B cells are a type of white blood cell. They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have ...

MIT has developed light-activated cell-wearable devices that mimic myelin and restore neuron function, offering hope for ...

Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s ...

In a world first, scientists have successfully used stem cell therapy to reverse type 1 diabetes in a woman. This achievement is being hailed as a major medical breakthrough, as it offers a ...

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially ...

B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus ...

Universal Cells—which Astellas refers to as its cell therapy research organization—is establishing a second location overseas at the Japanese pharma’s research campus in Tsukuba, an Astellas ...

Also last month, famed synthetic biology pioneer George Church announced a new startup that raised $75 million for a cell therapy platform that aims to deliver off-the-shelf iPSC medicines up to ...

A new cell therapy, targeting CD7 in leukemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic leukemia (T-ALL) who have exhausted all standard treatment ...